Prothena Corp Public (PRTA) EBT Margin (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly EBT Margin of 64.06% for Q1 2026, up 223425.0% year-over-year from N/an in Q1 2025, and up 100.06% quarter-over-quarter from 102757.14% in Q4 2025.
Prothena Corp Public (PRTA) EBT Margin (2012 - 2026) Analysis & Trends
Prothena Corp Public's EBT Margin history runs 15 years deep, the most recent figure standing at 64.06% for Q1 2026.
- In Q1 2026, EBT Margin rose 223425.0% year-over-year to 64.06%; the TTM figure through Mar 2026 stood at 184.21% (down 10022.0% YoY), while the FY2025 annual figure was 2073.82%, down 197843.0% from the prior year.
- EBT Margin for Q1 2026 stood at 64.06%, up from 102757.14% in the prior quarter.
- The five-year high for EBT Margin was 64.06% in Q1 2026, with the low at 148880.0% in Q1 2024.
- The 5-year median for EBT Margin is 2294.88% (2023), against an average of 17754.92%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin slumped 14658512 bps in 2024, then surged 14670981 bps in 2025.
- Prothena Corp Public's EBT Margin stood at 6.7% in 2022, then plunged by 333628 bps to 22347.47% in 2023, then surged by 87 bps to 2802.68% in 2024, then tumbled by 3566 bps to 102757.14% in 2025, then soared by 100 bps to 64.06% in 2026.
- Business Quant data shows PRTA's EBT Margin at 64.06% in Q1 2026, 102757.14% in Q4 2025, and 1528.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -1,839.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,839.70% |
| Mar 31, 2026 | 64.06% |
| Dec 31, 2025 | -102,757.14% |
| Sep 30, 2025 | -1,528.45% |
| Jun 30, 2025 | -1,831.79% |
| Mar 31, 2025 | -2,170.19% |
| Dec 31, 2024 | -2,802.68% |
| Sep 30, 2024 | -6,168.66% |
| Jun 30, 2024 | 49.12% |
| Mar 31, 2024 | -148,880.00% |
| Dec 31, 2023 | -22,347.47% |
| Sep 30, 2023 | 22.17% |
| Jun 30, 2023 | -1,465.56% |
| Mar 31, 2023 | -2,294.88% |
| Dec 31, 2022 | 6.70% |
| Sep 30, 2022 | -3,191.63% |
| Jun 30, 2022 | -3,244.82% |
| Mar 31, 2022 | -3,292.37% |
| Dec 31, 2021 | -2,823.89% |
| Sep 30, 2021 | 78.46% |